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LETTERS TO THE EDITOR
cently, we also demonstrated an up-regulation of uPARRelease of urokinase in tubular lesions associated to nephrotoxic nephritis in
the rat [4]. These results suggest that uPAR may play aplasminogen activator role in the pathogenesis of acute renal failure related to
acute tubular necrosis, either by focalizing uPA activityreceptor during urosepsis at the cell surface and promoting cell detachment from
the basement membrane, or by facilitating cell migrationand endotoxemia and recovery of tubular integrity. Experimental models
of acute tubular necrosis in uPAR knockout animals
would be helpful to determine if uPAR plays a patho-To the Editor: In the June 2001 issue of Kidney Inter-
genic role and whether it is deleterious or beneficial fornational, Florquin et al clearly show a strong and early
the kidney.upregulation of urokinase plasminogen activator recep-
tor (uPAR) in renal tubular epithelial cells during pyelo- Eric Rondeau
nephritis and an increase in both blood and urine levels Paris, France
of soluble uPAR during endotoxemia [1]. The authors
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E-mail: eric.rondeau@tnn.ap-hop-paris.frkidney that indicated that uPAR was found in all seg-
ments of the tubular epithelium in normal renal tissue
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transporters that lead to hypokalemia, volume depletion,Reduced content of  subunit as well as activation of the renin-angiotensin-aldosterone
system. In addition, patients with Bartter and Gitelmanof Gq protein content in syndromes present with normotension/hypotension, re-
duced peripheral resistance, and hyporesponsiveness tomonocytes of Bartter and pressors [1]. We recently provided a mechanistic expla-
nation for the decreased vascular reactivity characteristicGitelman syndromes: of Bartter and Gitelman syndromes by demonstrating
that there is a defective coupling of the agonist receptorRelationship with vascular to phospholipase C, at the level of the G subunit of the
Gq-binding protein. Protein kinase C activity is thereforehyporeactivity reduced, thereby inducing vascular hyporeactivity [2].
As the reduced expression of the Gq was based on
mRNA level [2], a direct demonstration of a correspon-
To the Editor: The clinical picture of Bartter and Gi- dent decrease in the abundance of Gq protein was
telman syndromes reflects functional defects in kidney required to further strengthen the existence of a defect
in the intracellular biochemical sequence of events that
leads to vascular hyporeactivity in Bartter and Gitelman
syndromes [3]. 2002 by the International Society of Nephrology
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